April 25 (Reuters) - Merck & Co ( MRK ) on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine Gardasil. The New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its previous prediction of $8.44 to $8.59,...

07:00 AM EDT, 04/25/2024 (MT Newswires) -- Merck ( MRK ) reported Q1 non-GAAP earnings Thursday of $2.07 per share, up from $1.40 a year ago. Analysts polled by Capital IQ expected $1.92. Sales for the quarter ended March 31 were $15.78 billion, up from $14.49 billion a year earlier. Analysts surveyed by Capital IQ expected $15.20 billion. For 2024,...

April 25 (Reuters) - Bristol Myers Squibb ( BMY ) on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio and Mirati Therapeutics offset a 5% increase in revenue. The New Jersey-based drugmaker posted a loss of $4.40 per share, including charges for acquired research and development. Analysts on average had expected a...

(Reuters) -Harley-Davidson ( HOG ) posted a 23% decline in first-quarter profit on Thursday, hurt by slow sales of its motorcycles in North America as high borrowing costs deter potential buyers from making expensive purchases. Despite Harley's attempt to spruce up its offerings with electric options, the 120-year-old motorcycle maker has not been highly successful in attracting millennials, forcing it...